Advertisement

Is Breast Cancer Curable?

  • Gilbert H. Fletcher
Part of the Medical Radiology book series (MEDRAD)

Abstract

After investigating breast cancer mortality since 1900, some epidemiologists in the middle of this Century reached the conclusion that survival rates (using a 5-year survival index) of patients with breast cancer were not affected by treatment at all (Park and Lees 1951). Other authors concluded, by constructing mathematical models of the behavior of breast cancer, that the same proportion of patients at any time during follow-up experience failure, indicating that eventually all patients die from breast cancer (Cutler and Axtell 1963). Other studies indicate that less than 15% of breast cancer patients with positive axillary lymph nodes will be free of disseminated disease (BROSS and BLUMENSON 1971). These hypotheses support the predominant view that nearly all breast cancer patients with histologically positive axillary nodes die of disease, thereby raising the controversial question of whether breast cancer is curable (Brinkley and Haybittle 1977; Bross and Blumenson 1971; Fletcher 1984; Harris and Hellmann 1986; Rutqvist et al. 1984). In this chapter, these hypotheses are tested on a series of 941 patients treated at the University of Texas M. D. Anderson Cancer Center (UTMDACC) be- tween 1963 and 1979; follow-up was a minimum of 14 years to a maximum of 28 years.

Keywords

Breast Cancer Breast Cancer Patient Positive Node Positive Axillary Node Locoregional Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adair F, Berg J, Jourbert L, Robbins GF (1974) Long-term follow-up of breast cancer patients: the 30-year report. Cancer 33: 1145–1150PubMedCrossRefGoogle Scholar
  2. Berkson J, Gage R (1950) Calculation of survival rates for cancer. Proc Mayo Clinic 25: 270Google Scholar
  3. Brinkley D, Haybittle JL (1977) The curability of breast cancer. Lancet ii: 95–97Google Scholar
  4. Bross IDJ, Blumenson LE (1971) Predictive design of experiments using deep mathematical models. Cancer 28: 1637–1646PubMedCrossRefGoogle Scholar
  5. Cutler SJ, Axteil SJ (1963) Partitioning of a patient population with respect to different mortality risks. Am Stat Ass J 701–712Google Scholar
  6. Fletcher GH (1976) Reflections on breast cancer. Int J Radiat Oncol Biol Phys 1: 769–779PubMedCrossRefGoogle Scholar
  7. Fletcher GH (1984) The enigma of breast cancer. In: Arnes FC, Blumenschein GR, Montague ED (eds) Current controversies in breast cancer. University of Texas Press, Austin, Texas, pp 139–147Google Scholar
  8. Fletcher GH, McNeese MD, Owald MJ (1989) Long-range results for breast cancer patients treated by radical mastectomy and postoperative radiation without adjuvant chemotherapy: an update. Int J Radiat Oncol Biol Phys 17: 11–14PubMedGoogle Scholar
  9. Haagensen CD (1956) Diseases of the breast, 2nd edn. Saunders, PhiladelphiaGoogle Scholar
  10. Harris JR, Hellman S (1986) Observations on survival curve analysis and particular reference to breast cancer treatment. Cancer 67: 925–928CrossRefGoogle Scholar
  11. Park WW, Lees JD (1951) The absolute curability of cancer of the breast. Surg Gyn Obstet 93: 129–152Google Scholar
  12. Rutqvist LE, Wallgren A, Nilsson B (1984) Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the cancer registry of Norway. Cancer 63: 1793–1800CrossRefGoogle Scholar
  13. Spratt JS, Donegan WL (1967) Cancer of the breast. Saunders, PhiladelphiaGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • Gilbert H. Fletcher
    • 1
  1. 1.Department of RadiotherapyM.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations